TMSOF — THOMSON REUTERS CORP /CAN/

Nasdaq · Unknown · Unknown · CIK 1075124 ·
Last close
$11.51
Market Cap
52W High
$11.51
52W Low
$11.31
ADV30
0
Next earnings
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 2,087,000,000 639,000,000 459,000,000 17,944,000,000 400,000,000 6,132,000,000
Dec 2025 2,009,000,000 1,516,000,000 378,000,000 332,000,000 17,940,000,000 371,000,000 6,026,000,000
Sep 2025 1,782,000,000 1,352,000,000 598,000,000 423,000,000 17,850,000,000 618,000,000 6,089,000,000
Jun 2025 1,785,000,000 1,347,000,000 443,000,000 313,000,000 17,966,000,000 664,000,000 5,350,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,710,000,000
Investing CF
$-895,000,000
Financing CF
$-2,788,000,000
CapEx
$-639,000,000
Dividends Paid
$-1,060,000,000
Buybacks
$-1,262,000,000
EPS Diluted TTM
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$9,150,000,000
Inventory
$23,000,000
Receivables
$1,184,000,000
ST Investments
$89,000,000
EBIT TTM
$2,196,000,000
Pretax Income TTM
$2,020,000,000
Interest Exp TTM
$176,000,000
Analysts

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 7,476,000,000 1,989,000,000 1,502,000,000 17,940,000,000 6,026,000,000 2,651,000,000
Dec 2024 7,258,000,000 1,896,000,000 2,210,000,000 18,437,000,000 6,431,000,000 2,457,000,000
Dec 2023 6,794,000,000 1,950,000,000 2,695,000,000 18,684,000,000 7,620,000,000 2,341,000,000
Dec 2022 6,627,000,000 1,815,000,000 1,338,000,000 21,711,000,000 9,826,000,000 1,915,000,000

Peers — same industry

TickerNameMarket CapLastDaily %
SPY SPDR S&P 500 ETF TRUST $685.61B $747.03
QQQ INVESCO QQQ TRUST, SERIES 1 $270.45B $687.99
KLAC KLA CORP $238.81B $182.82
TMO THERMO FISHER SCIENTIFIC INC. $213.42B $574.30
IBM INTERNATIONAL BUSINESS MACHINES CORP $210.71B $223.65

News headlines (Yahoo Finance, 1h cache)

What Analyst Projections for Key Metrics Reveal About Thomson Reuters (TRI) Q2 Earnings
2026-07-31 13:15 · Yahoo
Thomson Reuters (TRI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
2026-07-29 14:00 · Yahoo
INTU Down 60%: Is Intuit's Proven Price Floor About To Break?
2026-07-28 00:33 · Yahoo
Will Thomson Reuters (TRI) Beat Estimates Again in Its Next Earnings Report?
2026-07-27 16:10 · Yahoo
Thomson Reuters (TSX:TRI) Stock May Be Undervalued After AI Restructuring
2026-07-24 19:11 · Yahoo
The Hidden Volatility Brewing Inside Intuit Stock
2026-07-24 16:37 · Yahoo
Thomson Reuters (TSX:TRI) Could Be 40% Undervalued On Its Durability Narrative
2026-07-24 06:10 · Yahoo
History Has An Opinion On This INTU Price Level
2026-07-23 15:28 · Yahoo
The Cash Machine The Market Put On Sale: INTU
2026-07-22 19:39 · Yahoo
ZETA's AI Momentum is Strong, but Can Execution Keep Up?
2026-07-17 18:11 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.